OrphanDrug
OrphanDrug
Pharma Knowledge Base

alpha-thalassemia-myelodysplastic syndrome

MeSH: C563023ORPHA: 231401

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with alpha-thalassemia-myelodysplastic syndrome, sourced from HPO and Orphanet clinical annotations.

Bruising susceptibilitySplenomegalyThrombocytopeniaDecreased total neutrophil countAbnormal bleedingMicrocytic anemiaDyspneaAcute leukemiaImmunodeficiencyMyelodysplasiaHbH hemoglobinFatigue

Classification & Codes

MeSH Code

C563023

Orphanet Code

ORPHA:231401
alpha-thalassemia-myelodysplastic syndrome
MeSHC563023
OrphanetORPHA:231401
Treatments0 drug(s)
Symptoms on record12 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO